Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29523536 | 0.72 | — | — | |
| SCHEMBL20357486 | 0.68 | — | — | |
| SCHEMBL6852004 | 0.67 | — | — | |
| SCHEMBL3004287 | 0.67 | — | — | |
| SCHEMBL10875328 | 0.67 | POLA1 (0.47) | — | |
| SCHEMBL30161740 | 0.66 | THRB (0.38) | — | |
| SCHEMBL11823555 | 0.66 | — | — | |
| SCHEMBL2469708 | 0.66 | — | — | |
| SCHEMBL27937457 | 0.64 | — | — | |
| SCHEMBL29966390 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260009056-A1 | PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES | ZYMOCHEM INC (US) | 2026-01-08 | — | — | US | disclosed |
| US-12258610-B2 | Production of chemicals from renewable sources | ZYMOCHEM, INC. (US) | 2025-03-25 | — | — | US | disclosed |
| US-11692208-B2 | Production of chemicals from renewable sources | ZYMOCHEM, INC. (US) | 2023-07-04 | — | — | US | disclosed |
| US-20230109883-A1 | PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES | ZYMOCHEM, INC. | 2023-04-13 | — | — | US | disclosed |
| US-20220372528-A1 | PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES | ZYMOCHEM, INC. | 2022-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260009056-A1 | PRODUCTION OF CHEMICALS FROM RENEWABLE SOURCES | HPD, PGD, ADSL | MAPK1 2601/4885SLC13A3 1133/4885EGLN1 748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.